These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24443567)

  • 1. Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.
    Nikolajsen CL; Dyrlund TF; Poulsen ET; Enghild JJ; Scavenius C
    J Biol Chem; 2014 Mar; 289(10):6526-6534. PubMed ID: 24443567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
    Richardson VR; Cordell P; Standeven KF; Carter AM
    Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.
    Anokhin BA; Dean WL; Smith KA; Flick MJ; Ariëns RAS; Philippou H; Maurer MC
    FEBS J; 2020 Feb; 287(3):452-464. PubMed ID: 31407850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human complement C3 is a substrate for transglutaminases. A functional link between non-protease-based members of the coagulation and complement cascades.
    Nikolajsen CL; Scavenius C; Enghild JJ
    Biochemistry; 2012 Jun; 51(23):4735-42. PubMed ID: 22630814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methods for the determination of factor XIII/XIIIa].
    Wilmer M; Schröder V; Kohler HP
    Hamostaseologie; 2002 Feb; 22(1):32-42. PubMed ID: 12193983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
    Bagoly Z; Haramura G; Muszbek L
    Thromb Haemost; 2007 Aug; 98(2):359-67. PubMed ID: 17721618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.
    Doiphode PG; Malovichko MV; Mouapi KN; Maurer MC
    Anal Biochem; 2014 Jul; 457():74-84. PubMed ID: 24751466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa.
    Sheffield WP; Eltringham-Smith LJ
    BMC Biotechnol; 2011 Dec; 11():127. PubMed ID: 22185689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let's cross-link: diverse functions of the promiscuous cellular transglutaminase factor XIII-A.
    Mitchell JL; Mutch NJ
    J Thromb Haemost; 2019 Jan; 17(1):19-30. PubMed ID: 30489000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation factor XIIIa cross-links amyloid β into dimers and oligomers and to blood proteins.
    Hur WS; Mazinani N; Lu XJD; Yefet LS; Byrnes JR; Ho L; Yeon JH; Filipenko S; Wolberg AS; Jefferies WA; Kastrup CJ
    J Biol Chem; 2019 Jan; 294(2):390-396. PubMed ID: 30409906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of blood coagulation factor XIII.
    Schmitz T; Bäuml CA; Imhof D
    Anal Biochem; 2020 Sep; 605():113708. PubMed ID: 32335064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
    Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S
    Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-peptide based assay for the characterization of human blood coagulation factor XIII-A isopeptidase activity.
    Csobán-Szabó Z; Fésüs L; Király R
    Anal Biochem; 2020 Jul; 600():113699. PubMed ID: 32335063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function.
    Duval C; Allan P; Connell SD; Ridger VC; Philippou H; Ariëns RA
    Thromb Haemost; 2014 May; 111(5):842-50. PubMed ID: 24430058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.
    Wang W
    J Biol Chem; 2011 Dec; 286(52):44952-64. PubMed ID: 22030394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor XIIIa is inactivated by plasmin.
    Hur WS; Mazinani N; Lu XJ; Britton HM; Byrnes JR; Wolberg AS; Kastrup CJ
    Blood; 2015 Nov; 126(20):2329-37. PubMed ID: 26359437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethacrynic acid is an inhibitor of human factor XIIIa.
    Kar S; Vu K; Mottamal M; Al-Horani RA
    BMC Pharmacol Toxicol; 2022 Jun; 23(1):35. PubMed ID: 35642005
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.